Remiges Ventures (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:Cambridge

Remiges Ventures is an American venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Average round investment:12.45M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Germany Kupando
Mostly invests in: Germany Germany (1) Health services (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Remiges Ventures

Name Criteria
Sweden Novax
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United Kingdom Wellington Partners
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Belgium Gemma Frisius Fund
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Netherlands Enterprise Agency
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany 2invest
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Alef 6
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Ace Ventures
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Hyloris Pharmaceuticals
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Ilmarinen
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Italy Ersel
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top